Temozolomide is a triazene analog of dacarbazine with antineoplastic activity.
As a cytotoxic alkylating agent, temozolomide is converted at physiologic pH to the short-lived active compound, monomethyl triazeno imidazole carboxamide (MTIC).

Product Name Temozolomide
CAS Number 85622-93-1
Therapeutic Class Antineoplastic Agents, Alkylating
Dosage Form Oral Capsule, Powder for injection
Availability Commercial
Regulatory Status USDMF, EDMF, CADMF